how long to hold glp-1 before surgery ASA Advises No Longer Holding Agents Prior for Most Patients Perioperative Considerations for Patients on

Tirzepatide (Mounjaro, Zepbound) : A dual GLP-1/GIP receptor agonist approved for diabetes and weight management

At the highest dose, participants lost an average of about 12% of their body weight, along with improvements in cardiometabolic risk factors

GLP-1 users often report greater sensitivity to sweetness and heaviness, making lighter drinks easier to tolerate and more enjoyable

While Oprah obviously cares about her personal health, this People story is part of a broader marketing blitz to grab attention, get people on-platform (ESPECIALLY with the new year almost here, new weight loss goals you guys!!) , and destigmatize the shame around the obesity conversation

The company attributed the shortfall to increased operating expenses and lower patient volumes

A meta-analysis of studies does show that people who lose more weight (e.g